The document details Takeda California's assessment of clonality in production cell lines using high-resolution imaging, emphasizing the FDA's requirement for monoclonality in commercial cell substrates. The study explores the optimization of media conditions, methods for tracking single cell growth, and the impact of additives on colony growth, concluding that lower seeding densities improve colony yield from single cells. Ongoing work aims to refine the system to reduce false negatives and validate whether one round of subcloning is adequate.